Arcutis Biotherapeutics Inc (ARQT) stock news · rev $376.1M
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
This ARQT news page leads with what Arcutis Biotherapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ARQT yet. We will not pad this page with generic market recap.
Latest reported ARQT revenue for 2025-12-31 was $376.1M. Net income was -$16.1M. Revenue was up 91.3% from 2024-12-31 to 2025-12-31. ARQT currently screens at market cap $1.64B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ARQT stock page; for the tape open the quote page.
ARQT stock news FAQ
What are ARQT's latest revenue and net income?
Latest cached Arcutis Biotherapeutics Inc (ARQT) revenue for Dec 31, 2025 was $376.1M. Net income was -$16.1M. Statements: https://lician.com/financials/arqt
How did ARQT revenue change from the prior cached period?
Cached Arcutis Biotherapeutics Inc (ARQT) revenue was up 91.3% from $196.5M (Dec 31, 2024) to $376.1M (Dec 31, 2025). Statements: https://lician.com/financials/arqt
What is ARQT's market cap?
Arcutis Biotherapeutics Inc (ARQT) market cap is $1.64B on the latest cached fundamentals snapshot.
What kind of company is ARQT?
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Where is ARQT stock news listed?
Cached stock news for Arcutis Biotherapeutics Inc (ARQT) is listed at https://lician.com/news/arqt. Filings: https://lician.com/sec/arqt
Not investment advice.